Hydroethanolic extract of lampaya medicinalis phil. (verbenaceae) decreases proinflammatory marker expression in palmitic acid-exposed macrophages
Artículo
Access note
Acceso a solo metadatos
Publication date
2020Metadata
Show full item record
Cómo citar
Ormazábal, Paulina
Cómo citar
Hydroethanolic extract of lampaya medicinalis phil. (verbenaceae) decreases proinflammatory marker expression in palmitic acid-exposed macrophages
Author
Abstract
Background: Obesity is a major health problem associated with increased comorbiditics, which are partially triggered by inflammation. Proinflaminatory macrophage infiltration in adipose tissue of individuals with obesity increases chronic inflammation. Obesity is associated with elevated plasma levels of saturated fatty acids, such as palmitic acid (PA), which promotes inflammation in vivo and in vitro. Infusions of Lampaya medicinalis Phil. (Verbenaceae) are used in the folk medicine of Northern Chile to counteract inflammation of rheumatic diseases. Hydroethanolic extract of lampaya (HEL) contains spectrophotometrically defined compounds that may contribute to the observed effect on inflammation.
Methods: We evaluated the phytochemical composition of HEL by high-performance liquid chromatography coupled to diode array detection (HPLC-DAD) and liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS). We assessed whether the exposure to HEL affects PA-induced expression of proinflammatory factors in THP-1 macrophages.
Results: HPLC-DAD and LC-ESI-MS/MS analyses showed the presence of considerable amounts of flavonoids in HEL. The PA-induced phosphorylation of the inflammatory pathway mediators IKK and NF-kappa B, as well as the elevated expression and secretion of proinflammatory cytokines (IL-6, TNF-alpha), were reduced in cells pre-exposed to HEL.
Conclusion: These findings give new insights about the effect of HEL reducing IKK/NF-kappa B proinflammatory pathway, likely explained by the number of flavonoids contained in the extract. More studies would be needed to define the possible role of Lampaya as a preventive approach in subjects with obesity whose circulating PA might contribute to chronic inflammation.
Patrocinador
Universidad de O'Higgins research fund
Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)
CONICYT FONDECYT
1150651
Network for Extreme Environments Research (NEXER)
ANT1756
Universidad de Antofagasta, Chile
Indexation
Artículo de publicación ISI Artículo de publicación SCOPUS
Identifier
URI: https://repositorio.uchile.cl/handle/2250/180022
DOI: 10.2174/1871530320666200513082300
Quote Item
Endocrine Metabolic & Immune Disorders-Drug Targets Volumen: 20 Número: 8 Páginas: 1309-1320 (2020)
Collections